Two Sigma Securities, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Two Sigma Securities, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $96,628 - $131,376	-1,400 Reduced 13.33%	9,100 $639,000
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $781,515 - $968,310	10,500 New	10,500 $864,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $657,624 - $798,072	-8,800 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $363,050 - $451,000	-5,000 Reduced 36.23%	8,800 $772,000
Q2 2020 Sep 10, 2020	BUY	$79.55 - $124.22 $660,265 - $1.03 Million	8,300 Added 150.91%	13,800 $1.7 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $214,110 - $290,550	-3,000 Reduced 35.29%	5,500 $465,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $109,259 - $146,829	1,700 Added 25.0%	8,500 $719,000
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $60,660 - $76,599	900 Added 15.25%	6,800 $458,000
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $233,014 - $272,310	2,900 Added 96.67%	5,900 $505,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $75,780 - $88,758	900 Added 42.86%	3,000 $266,000
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $169,056 - $190,296	-1,800 Reduced 46.15%	2,100 $204,000
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $425,656 - $554,568	-5,600 Reduced 58.95%	3,900 $367,000
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $388,350 - $463,150	5,000 Added 111.11%	9,500 $770,000
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $363,420 - $428,085	4,500	4,500 $401,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.